|
Volume
21 Number 2
February 2019
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
21, Year 2019 >
Number 2, February
|
|
|
|
|
|
Wang X, Guo G, Guan H, Yu Y, Lu J, Yu J.
Challenges
and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for
glioblastoma.
J
Exp Clin Cancer Res. 2019 Feb 18,
2019;38(1):87→.
doi: 10.1186/s13046-019-1085-3→.
PMID: 30777100→.
Review. →
|
|
|
*
|
Chukwueke UN, Wen PY.
Use of the
Response Assessment in Neuro-Oncology (RANO) criteria in clinical
trials and clinical practice.
CNS Oncol. 2019 Feb
26, 2019;8(1):CNS28→.
doi: 10.2217/cns-2018-0007→.
PMID: 30806082→.
Review. →
|
|
|
Central
nervous system tumors
|
▲
|
|
Baliga S, Yock TI.
Proton beam therapy in pediatric
oncology.
Curr
Opin Pediatr. 2019 Feb;31(1):28-34. doi:
10.1097/MOP.0000000000000724.
_
|
|
|
|
Subramanian S, Ahmad T.
Cancer, Childhood Brain Tumors.
StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing NBK535415;
2018 Dec 4. _
|
|
|
Gliomas
|
▲
|
|
Chen TC, da Fonseca CO, Schönthal AH.
Intranasal
Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and
Clinical Development.
Int
J Mol Sci. 2018 Dec 6;19(12). doi:
10.3390/ijms19123905.
_
|
|
|
|
Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la
Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick
HH, Sattler B, Schuster DM, Tonn JC, Weller M.
Joint
EANM/EANO/RANO practice guidelines/SNMMI procedure standards for
imaging of gliomas using PET with radiolabelled amino acids and
[18F]FDG: version 1.0.
Eur
J Nucl Med Mol Imaging. 2018 Dec 5.
2019;46(3):540-557. doi: 10.1007/s00259-018-4207-9.
_
|
|
|
|
Lehrer S.
Glioma and Alzheimer's Disease.
J
Alzheimers Dis Rep. 2018 Dec 14;2(1):213-218. doi:
10.3233/ADR-180084.
_
|
|
|
|
Lu VM, Goyal A, Quinones-Hinojosa A, Chaichana KL.
Updated
incidence of neurological deficits following insular glioma
resection: A systematic review and meta-analysis.
Clin
Neurol Neurosurg. 2018 Dec 17. 2019;177:20-26. doi:
10.1016/j.clineuro.2018.12.013. _
|
|
|
|
Rynkeviciene R, Simiene J, Strainiene E, Stankevicius V,
Usinskiene J, Miseikyte Kaubriene E, Meskinyte I, Cicenas J,
Suziedelis K.
Non-Coding RNAs in Glioma.
Cancers
(Basel). 2018 Dec 22;11(1). doi: 10.3390/cancers11010017.
_
|
|
|
|
Sadeghi N.
Neuroimaging of Adult Gliomas: An Update.
J
Belg Soc Radiol. 2017 Nov 18;101(Suppl 1):8. doi:
10.5334/jbr-btr.1415. _
|
|
|
|
Zhao Z, Zhang K, Wang Z, Wang K, Liu X, Wu F, Chen J.
A
comprehensive review of available omics data resources and
molecular profiling for precision glioma studies.
Biomed
Rep. 2018 Nov 14. 2019;10(1):3-9. doi:
10.3892/br.2018.1168. _
|
|
|
Brain
stem gliomas
|
|
|
Rosen A, Anderson V, Bercovici E, Laperriere N, Rohan D'Souza.
Brainstem gliomas in pregnancy: a systematic review.
J
Matern Fetal Neonatal Med. 2018 Dec 18. 2018;1-311.
doi: 10.1080/14767058.2018.1560410.
_
|
|
|
High-grade
gliomas
|
|
|
Vatu BI, Artene SA, Staicu AG, Turcu-Stiolica A, Folcuti C, Dragoi
A, Cioc C, Baloi SC, Tataranu LG, Silosi C, Dricu A.
Assessment
of efficacy of dendritic cell therapy and viral therapy in high
grade glioma clinical trials. A meta-analytic review.
J
Immunoassay Immunochem. 2018 Nov 30.
2019;40(1):70-80. doi: 10.1080/15321819.2018.1551804.
_
|
|
|
Low-grade
gliomas
|
|
|
de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J.
Management of pediatric low-grade glioma.
Curr
Opin Pediatr. 2019 Feb;31(1):21-27. doi:
10.1097/MOP.0000000000000717.
_
|
|
|
|
Geurts M, van den Bent MJ.
On high-risk, low-grade
glioma: What distinguishes high from low?
Cancer.
2018 Dec 4. 2019;125(2):174-176. doi: 10.1002/cncr.31834.
_
|
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
▲
|
|
|
Glioblastoma
|
|
|
Branter J, Basu S, Smith S.
Tumour treating fields in a
combinational therapeutic approach.
Oncotarget.
2018 Nov 27;9(93):36631-36644. doi: 10.18632/oncotarget.26344.
_
|
|
|
|
Fernandes GFDS, Fernandes BC, Valente V, Dos Santos JL.
Recent
advances in the discovery of small molecules targeting
glioblastoma.
Eur
J Med Chem. 2018 Dec 16. 2019;164:8-26. doi:
10.1016/j.ejmech.2018.12.033. _
|
|
|
|
Grasso G, Torregrossa F, Leone L.
Maximizing the extent
of resection in high grade glioma.
World
Neurosurg. 2018 Dec 19. doi:
10.1016/j.wneu.2018.12.037. _
Comment
on: Chang KT
et
al, In Vivo Real-Time Discrimination Among Glioma, Infiltration
Zone, and Normal Brain Tissue via Autofluorescence Technology.
World
Neurosurg.
2018 Nov 1. doi: 10.1016/j.wneu.2018.10.144.
_
|
|
|
|
Kazmi F, Soon YY, Leong YH, Koh WY, Vellayappan B.
Re-irradiation
for recurrent glioblastoma (GBM): a systematic review and
meta-analysis.
J
Neurooncol. 2018 Dec 6. doi:
10.1007/s11060-018-03064-0. _
|
|
|
|
Lynes J, Sanchez V, Dominah G, Nwankwo A, Nduom E.
Current
Options and Future Directions in Immune Therapy for Glioblastoma.
Front
Oncol. 2018 Dec 5;8:578. doi:
10.3389/fonc.2018.00578.
_
|
|
|
|
Rahman M, Dastmalchi F, Karachi A, Mitchell D.
The role
of CMV in glioblastoma and implications for immunotherapeutic
strategies.
Oncoimmunology.
2018 Oct 16;8(1):e1514921. doi: 10.1080/2162402X.2018.1514921.
_
|
|
|
|
Riboni L
Cross-talk between tumor stem cells and tumor
cells: a glioblastoma strategy to promote malignancy.
Stem
Cell Investig. 2018 Oct 10;5:32. doi:
10.21037/sci.2018.09.04. _
Comment
on: Wang X
et
al, Reciprocal Signaling between Glioblastoma Stem Cells and
Differentiated Tumor Cells Promotes Malignant Progression. Cell
Stem Cell.
2018
Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.
_
|
|
|
|
Stepanenko AA, Chekhonin VP.
Recent Advances in Oncolytic
Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope
in the Search for an Effective Therapy?
Cancers
(Basel). 2018 Dec 5. 2018;10(12). doi: 10.3390/cancers10120492.
_
|
|
|
|
Stupp R.
Drug development for glioma: are we repeating
the same mistakes?
Lancet
Oncol. 2018 Dec 3. 2019;20(1):10-12. doi:
10.1016/S1470-2045(18)30827-1. _
Comment
on: Lombardi G
et
al, Regorafenib compared with lomustine in patients with relapsed
glioblastoma (REGOMA): a multicentre, open-label, randomised,
controlled, phase 2 trial. Lancet
Oncol.
2018 Dec 3. 2019;20(1):110-119. doi:
10.1016/S1470-2045(18)30675-2.
_
|
|
|
|
Tabibkhooei A, Fattahi A, Ebrahimnia F.
Gliosarcoma with
long progression free survival: A case report and literature
review.
Surg
Neurol Int. 2018 Nov 5. 2018;9:227. doi:
10.4103/sni.sni_225_18.
_
|
|
|
Anaplastic
oligodendroglioma
|
|
|
Singh VK, Singh S, Bhupalam L.
Anaplastic
oligodendroglioma metastasizing to the bone marrow: A unique case
report and literature review.
Int
J Neurosci. 2018 Dec 11. 2018;1-10. doi:
10.1080/00207454.2018.1557165. _
|
|
|
Embryonal
tumors
|
▲
|
.
|
Ma J, Ma S, Yang J, Jia G, Jia W.
Primary spinal
primitive neuroectodermal tumor: A single center series with
literature review.
J
Spinal Cord Med. 2018 Dec 18. 2018;1-9. doi:
10.1080/10790268.2018.1547862. _
|
|
|
Medulloblastoma
|
|
|
Cassia GSE, Alves CAPF, Taranath A, López NS, Oztekin O,
Gonçalves FG, Patay Z.
Childhood Medulloblastoma
Revisited.
Top
Magn Reson Imaging. 2018 Dec;27(6):479-502. doi:
10.1097/RMR.0000000000000184. _
|
|
|
|
Frappaz D, Faure-Conter C, Bonneville Levard A, Barritault M,
Meyronet D, Sunyach MP.
Medulloblastomas in adolescents
and adults - Can the pediatric experience be extrapolated?
Neurochirurgie.
2018 Dec 17. doi: 10.1016/j.neuchi.2018.10.007.
_
|
|
|
Atypical
theratoid/rhabdoid tumor
|
|
|
Chan V, Marro A, Findlay JM, Schmitt LM, Das S.
A
Systematic Review of Atypical Teratoid Rhabdoid Tumor in Adults.
Front
Oncol. 2018 Nov 28. 2018;8:567. doi:
10.3389/fonc.2018.00567. _
|
|
|
Neurofibromatosis
|
▲
|
|
D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V,
Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D,
Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W,
Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau
H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V,
Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud
D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K,
Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.
The molecular landscape of glioma in patients with
Neurofibromatosis 1.
Nat
Med. 2018 Dec 10. 2019;25(1):176-187. doi:
10.1038/s41591-018-0263-8.
_
|
|
|
|
Spyris CD, Castellino RC, Schniederjan MJ, Kadom N.
High-Grade
Gliomas in Children with Neurofibromatosis Type 1: Literature
Review and Illustrative Cases.
AJNR
Am J Neuroradiol. 2018 Dec 20. doi:
10.3174/ajnr.A5888.
_
|
|
|
Syndromes
|
|
|
Khattab A, Monga DK.
Turcot Syndrome.
StatPearls
[Internet].
Treasure Island (FL): StatPearls Publishing NBK534782;
2018 Dec 1. _
|
|
|
bottom
|
▲
|
|
|
